mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say
Ars Technica 2026-01-22
Summary:
The vaccines are tailor-made to target each patient's unique cancer.
Link:
https://arstechnica.com/health/2026/01/mrna-cancer-vaccine-shows-protection-at-5-year-follow-up-moderna-and-merck-say/From feeds:
Cyberlaw » Ars TechnicaMusic and Digital Media » Ars Technica